Pamela S Keim

Title: The Innovative Contributions of Pamela S. Keim

Introduction

Pamela S. Keim is a notable inventor based in San Mateo, CA, who has made significant contributions to the field of biotechnology. With a total of 4 patents, her work primarily focuses on methods and compositions related to the inhibition of β-secretase, a crucial enzyme in the study of Alzheimer's disease.

Latest Patents

Keim's latest patents include innovative methods and compositions for inhibiting β-secretase. These compositions involve a novel protease capable of cleaving β-amyloid precursor protein (APP) on the amino-terminal side of the β-amyloid peptide. The protease, designated as β-secretase, is integral to reaction systems used in screening assays. These assays monitor β-secretase modulated cleavage of APP and help identify potential β-secretase inhibitors. Additionally, antibodies are raised against peptides of β-secretase, and pharmaceutical compositions and methods comprise compounds identified through these screening assays.

Career Highlights

Throughout her career, Pamela S. Keim has worked with prominent companies in the biotechnology sector, including Athena Neurosciences, Inc. and Elan Pharmaceuticals, Inc. Her expertise and innovative approach have positioned her as a key figure in her field.

Collaborations

Keim has collaborated with notable professionals such as Sukanto Sinha and John P. Anderson, contributing to the advancement of research in her area of expertise.

Conclusion

Pamela S. Keim's contributions to biotechnology, particularly in the development of methods for inhibiting β-secretase, highlight her role as an influential inventor. Her work continues to impact the field and offers promising avenues for future research and therapeutic development.